Formation, mentorat et développement en début de carrière

La plateforme de formation, de mentorat et de développement en début de carrière permettra d’établir un programme de formation durable afin d’appuyer les nouveaux chercheurs et d’améliorer les capacités de recherche sur la thromboembolie veineuse. Notre programme de formation cherche à répondre aux besoins insatisfaits en matière de formation et à aider les jeunes chercheurs à lancer leur carrière. Il sera mis en œuvre conformément aux pratiques exemplaires par des mentors, nouveaux ou non, qui seront formés à cette fin. Nous chercherons avant tout à former ou à perfectionner les cliniciens-investigateurs et les cliniciens-scientifiques.  

L’équipe

Coresponsables de la plateforme

Leslie Skeith (Calgary, AB)
Sudeep Shivakumar (Halifax, NS)

Conseil des stagiaires

Chair: Miriam Kimpton - 2019-2020
Chair: Faizan Khan- 2018-2019
Chair: Rick Ikesaka - 2017-2018
Chair: Deborah Siegal- 2016-2017

Ce conseil est dirigé par des stagiaires, et tous les stagiaires participant aux activités du Réseau CanVECTOR y sont admissibles. Le conseil donne aux stagiaires l’occasion de collaborer entre eux et leur permet de communiquer leurs besoins, leurs préoccupations et leurs commentaires au Comité de direction scientifique du Réseau CanVECTOR. 

Comité d’allocation de bourses aux stagiaires

The role of the CanVECTOR Trainee Award Committee is to make decisions about the allocation of CanVECTOR training funds to trainee applicants.

Responsibilities

  • Develop the process and criteria for awarding training funds
  • Consider the availability of funding, including partner funding at academic institutions, when making decisions about awards
  • Endeavour to equitably award funding across CanVECTOR training sites, taking into consideration the applicant's preferences, the training capacity at CanVECTOR sites, and the ability of the site to meet the applicant's training needs
  • Review applications and recommend candidates for funding

Membership and Voting 

Voting members

  • Committee co-chairs
  • Committee members, as listed on the Trainee Award Committee membership roster
  • CanVECTOR directors as ex-officio members

Non-voting member

  • Manager of the CanVECTOR Training and Mentoring platform

Quorum

  • More than 50% of the members entitled to vote

Chair

The co-leads of the CanVECTOR Training and Mentoring Platform will act as committee co-chairs and will alternately chair committee meetings. 

Frequency of Meetings and Manner of Call

Meetings will be held at least biannually at the call of a committee co-chair.

The meetings will usually be held via teleconference, though may be called in person in conjunction with a CanVECTOR annual meeting or other gathering of the members.

Reporting

To the CanVECTOR directors and Scientific Steering Committee.

Committee Co-chairs 

  • Leslie Skeith (Calgary)
  • Sudeep Shivakumar (Halifax)

Committee Members

  • Shannon Bates (Hamilton)
  • Susan Kahn (Montreal)
  • Alejandro Lazo-Langner (London)
  • Agnes Lee (Vancouver)
  • Rita Selby (Toronto)
  • Vicky Tagalakis (Montreal)
  • Marc Carrier (Ottawa)

Ex-officio Member

  • Marc Rodger (CanVECTOR director)

Manager of the Training and Mentoring Platform

  • Jessie Micholuk

Bourse de Formation CanVECTOR 2015-2016

 

Bourse de recherche Thrombosis Canada CanVECTOR

Apprenant Institution Superviseur
Leslie Skeith  Universite d'ottawa Dr. Gonsalves

 

Biographie

Leslie Skeith

Dr. Skeith a complété sa résidence en médecine interne à Western University et sa résidence en hématologie à l’Université de Calgary. Elle a effectué sa recherche en Thrombose/Éducation médicale à l’Université d’Ottawa en 2017 et a terminé une maîtrise en éducation dans les professions de la santé à l’université University of Illinois à Chicago. Sa recherche portant sur l’éducation médicale se focalise sur la prise de décision clinique au cours des formations de sous-spécialité, et son intérêt de recherche clinique est dans le domaine de la thrombose et de la santé des femmes.

Le projet de recherche CanVECTOR de Dr. Skeith consiste à évaluer la prise de décision clinique et les variations pratiques parmi les spécialistes de la thrombose qui utilisent des cas pratiques complexes. Elle s’intéresse aussi à l’évaluation du rôle de HBPM et l’aspirine en prophylaxie chez les femmes qui souffrent du syndrome des antiphospholipides et de perte(s) de grossesse antérieure(s). 

 

Bourse de Formation CanVECTOR 2016-2017

 

Bourse de recherche CanVECTOR 

Apprenant Institution  Superviseur
Adi Klil-Drori McGill University  Dr. Tagalakis
Jameel Abdulrehman University of Toronto Dr. Selby
Rick Ikesaka University of Ottawa Dr. Carrier
Leslie Skeith University of Ottawa Dr. Gonsalves

 

Bourse de recherche Thrombose Canada CanVECTOR 2016-2017

Apprenant Institution Superviseur
Mihir D. Bhatt McMaster University Dr. A. Chan

 

Bourse de début de recherche CanVECTOR 2016-2017

Apprenant Institution Superviseur
Rick Ikesaka University of Ottawa Dr. Carrier
Nicholas Meti McGill University Dr. Tagalakis
Mansoor Radwi McMaster University Dr. Douketis
Dwip Prajapati University of Calgary Dr. Lang & Dr. Suryanarayan

 

Bourse de déplacement CanVECTOR 2016-2017

Apprenant Institution
Adi Klil-Drori McGill University
Leslie Skeith University of Ottawa

 

CAEP / CanVECTOR Awards

Apprenant Award Type
Kerstin de Wit Research Award
Eddy Lang Abstract Award
Sameer Sharif Abstract Award

 

Les biographies

Jameel Abdulrehman

Dr. Abdulrehman completed his Internal Medicine residency at Western University and completed his residency in adult hematology at the University of Toronto in 2016. He is currently completing his clinical fellowship in thrombosis and hemostasis at the University of Toronto.

Dr. Abdulrehman's CanVECTOR project aims to investigate the use of ROTEM in predicting VTE in adult trauma patients.

 
 

Rick Ikesaka

Dr. Ikesaka previously completed his Internal Medicine residency and has completed his hematology residency, both at the University of Ottawa, Dept. of Medicine. He is currently completing a Master of Science in Epidemiology and Thrombosis research fellowship.

Dr. Ikesaka's CanVECTOR project's objective is to compare primary thromboprophylaxis with rivaroxaban in patients with malignancy and central venous catheters. Rick plans to complete a pilot studies to prove the viability, safety and efficacy of this prophylaxis strategy.

 
 

Leslie Skeith

Dr. Skeith completed her Internal Medicine residency at Western University and her Hematology residency at the University of Calgary. She completed her Thrombosis/Medical Education fellowship at the University of Ottawa in 2017 and is completing a Master of Health Professions Education at the University of Illinois at Chicago (UIC). Her medical education research focus is in clinical decision-making in sub-specialty training, and her clinical research interest is in the area of thrombosis and women's health.

For Dr. Skeith's CanVECTOR research project she is evaluating clinical decision making and practice variation among thrombosis specialists' using complex practice cases. She is also interested in evaluating the role of LMWH and aspirin prophylaxis in women with antiphosphospholipid syndrome and past pregnancy loss.

 
 
 

Adi Klil-Drori

Dr. Klil-Drori completed his Internal Medicine boards and Hematology boards in Israel, in 2011 and 2013 respectively.  He is currently completing a clinical epidemiology, Master of Science at Hebrew University, Jerusalem, Israel and will complete his Postdoctoral research fellowship at the Centre for Clinical Epidemiology, Jewish General Hospital and McGill University this year. He is also starting a 2-year clinical fellowship in early drug development in medical oncology.

Dr. Klil-Drori's CanVECTOR project includes using population-based administrative databases to capture outpatient management of PE across Quebec, Alberta and Ontario. A few of his database analysis objectives include; review of the changes of clinical outcomes in outpatient management of PE from the pre-DOAC era (2000-2009); compare outcomes of outpatient and inpatient management of PE in a subset of low-risk PE patients in the pre-DOAC era, and to examine whether market entry of DOAC for the treatment of PE has affected the practice of outpatient management of PE

 
 

Mihir Bhatt

Dr. Bhatt completed his undergraduate degree in Bachelor of Health Sciences, followed by MD, residency in Pediatrics and fellowship in Pediatric Hematology/Oncology all at McMaster University. Dr. Bhatt is an active researcher with a special interest in pediatric hemostasis and thrombosis.

Dr. Bhatt's Thrombosis Canada/CanVECTOR project includes assessing the feasibility and safety of a multicenter trial administering weight adjusted FiXEd dose of low molecular weight heparin (Enoxaparin) to neonates with Thrombosis (FiXET Study).

 

Bourse de Formation CanVECTOR 2017-2018

 

Bourse de recherche CanVECTOR 2017-2018

Apprenant Institution  Superviseur
Adi Klil-Drori McGill University  Dr. Tagalakis
Jameel Abdulrehman University of Toronto Dr. Selby
Fatimah Al-Ani The University of Western Ontario Dr. Lazo-Langner
Rick Ikesaka Universite d'ottawa Dr. Carrier
Siavash Piran McMaster University Dr. Schulman

 

Bourse d'etudes CanVECTOR 2017-2018

Apprenant Institution Superviseur
Hasam Madarati McMaster University Dr. Kretz
Kanwal Singh McMaster University Dr. Kretz

 

CAEP / CanVECTOR Awards

Trainee Award Type
Cristian Toarta Research Award

 

The Heart and Stroke Foundation (HSF) Emerging Research Leaders Initiative (ERLI) Award

Trainee Institution Supervisor
Deborah Siegal McMaster University Dr. Crowther

 

Les biographies

Jameel Abdulrehman

Dr. Abdulrehman completed his Internal Medicine residency at Western University and completed his residency in adult hematology at the University of Toronto in 2016. He is currently completing his clinical fellowship in thrombosis and hemostasis at the University of Toronto.

Dr. Abdulrehman's CanVECTOR project aims to investigate the use of ROTEM in predicting VTE in adult trauma patients.

 

Rick Ikesaka

Dr. Ikesaka previously completed his Internal Medicine residency and has completed his hematology residency, both at the University of Ottawa, Dept. of Medicine. He is currently completing a Master of Science in Epidemiology and Thrombosis research fellowship.

Dr. Ikesaka's CanVECTOR project's objective is to compare primary thromboprophylaxis with rivaroxaban in patients with malignancy and central venous catheters. Rick plans to complete a pilot studies to prove the viability, safety and efficacy of this prophylaxis strategy.

 
 

Fatimah Al-Ani

Dr. Fatimah Al-Ani obtained her medical degree from Baghdad, Iraq. She completed her training in Internal Medicine and in Hematology in Dubai, United Arab Emirates. Dr. Al-Ani obtained her Post Graduate Degree of Internal Medicine from the Royal College of Physicians of United Kingdom (MRCP of UK) in 2011. Upon moving to Canada, she joined Western University and completed a 3-year Research Fellowship in Hematology. Currently, she is pursuing a clinical fellowship in Adult Thrombosis Medicine at Western University. Dr. Al-Ani's CanVECTOR project aims to develop a clinical prediction rule for the risk of venous thromboembolism in patients with acute leukemia. Her research interests are in Thromboembolism, population based studies, and systematic reviews. Her other ongoing projects include Validation of diagnostic algorithms for Venous Thromboembolism Using Linked Health Care Databases, and a systematic review of the efficacy and safety of DOACS in population based studies.

 
 

Adi Klil-Drori

Dr. Klil-Drori completed his Internal Medicine boards and Hematology boards in Israel, in 2011 and 2013 respectively.  He is currently completing a clinical epidemiology, Master of Science at Hebrew University, Jerusalem, Israel and will complete his Postdoctoral research fellowship at the Centre for Clinical Epidemiology, Jewish General Hospital and McGill University this year. He is also starting a 2-year clinical fellowship in early drug development in medical oncology.

Dr. Klil-Drori's CanVECTOR project includes using population-based administrative databases to capture outpatient management of PE across Quebec, Alberta and Ontario. A few of his database analysis objectives include; review of the changes of clinical outcomes in outpatient management of PE from the pre-DOAC era (2000-2009); compare outcomes of outpatient and inpatient management of PE in a subset of low-risk PE patients in the pre-DOAC era, and to examine whether market entry of DOAC for the treatment of PE has affected the practice of outpatient management of PE

 
 

Siavash Piran

Dr. Siavash Piran graduated from University of Ottawa medical school in 2011. He completed his residency training in Internal Medicine at University of Ottawa and Hematology at McMaster University. 

He holds a Masters of Science degree in Laboratory Medicine and Pathobiology from the University of Toronto and completed a Masters of Science degree in Health Research Methodology at McMaster University. Dr. Piran is currently a Clinical Scholar in the Division of Hematology and Thromboembolism at McMaster University. His CanVECTOR project is a pilot study on thromboprophylaxis for patients with spinal cord injury comparing low-molecular-weight heparin with apixaban.

 
 

Kanwal Singh

Kanwal is pursuing a Master's degree in the Medical Sciences Program at McMaster University. He is interested in understanding the biochemistry and physiology of blood coagulation proteases. Kanwal's CanVECTOR project investigates the regulation of the metalloprotease ADAMTS13, which controls the platelet-capturing activity of von Willebrand factor. Because von Willebrand factor is known to play a crucial role in the initiation phase of blood coagulation, improving our understanding ADAMTS13 may yield important insights into pathophysiology of VTE and other thrombotic disorders. His long term goal is to translate the unique properties of ADAMTS13 to other proteases in the cardiovascular system, which may have broad clinical impact on protease replacement therapy.

 

Bourse de Formation CanVECTOR 2018-2019

 

Bourse de recherche CanVECTOR 2018-2019

Apprenant Institution  Superviseur
Miriam Kimpton Universite d'ottawa Dr. Marc Carrier
Zachary Liederman University of Toronto Dr. Rita Selby
Federico Germini McMaster University Dr. Kerstin de Wit
Thomas Moumneh Universite d'ottawa Dr. Gregoire Le Gal

 

Bourse d'étude CanVECTOR 2018-219

Trainee Institution Supervisor
Vidushi Swarup McMaster University Dr. Kerstin de Wit
Sarah Medeiros McMaster University Dr. Patricia Liaw
Luca Di Giuseppantonio  McMaster University   Dr. Paul Kim

 

Bourses de début de recherche CanVECTOR 2018-2019

Apprenant Institution Superviseur
Teresa Cafaro McGill University   Dr. Maral Koolian
Justin Tabah McGill University Dr. Vicky Tagalakis
Luca Di Giuseppantonio McMaster University  Dr. Paul Kim
Ali Mulla McMaster University Dr. Kerstin de Wit
Nicholas Jackson Chornenki McMaster University Dr. Deborah Siegal
Farheen Manji University of Calgary Dr. Deepa Suryanarayan
Marissa Laureano McMaster University Dr. Deborah Siegal
Christopher Cipkar Universite d'ottawa Dr. Lana Castellucci

 

Bourse de Formation CanVECTOR 2019-2020

 

Bourse de recherche Thrombosis Canada-CanVECTOR 2019-2020

Trainee Institution  Supervisor
Miriam Kimpton University of Ottawa Dr. Marc Carrier
     

 

Bourse de recherche CanVECTOR 2019-2020

Apprenant Institution  Superviseur
Tobias Tritschler Universite d'ottawa Dr. Gregoire Le Gal
Siraj Mithoowani McMaster University Dr. Mark Crowther
Keerat Grewal University of Toronto Dr. Kerstin de Wit

 

Bourse d'étude CanVECTOR 2019-2020

Apprenant Institution Superviseur
Sahar Sohrabipour McMaster University Dr. Patricia Liaw
Angela Lee McGill University Dr. Susan Kahn 
Amy Strilchuk University of British Columbia  Dr. Christian Kastrup

 

Bourse de début de recherche CanVECTOR 2019-2020

Apprenant Institution Superviseur
Angela Lee McGill university Dr. Susan Kahn
Denis Yahiaoui McGill University Dr. Vicky Tagalakis
Melissa Hanson Universite d'ottawa Dr. Elianna Saidenberg
Miriam Kimpton Universite d'ottawa Dr. Marc Carrier
Yan Xu University of Toronto Dr. Marc Carrier

 

Bourse de Formation CanVECTOR 2020-2021

CanVECTOR 2020-2021 Fellowship Awards 

Trainee Institution  Supervisor
Joseph Shaw University of Ottawa Dr. Marc Carrier
Erica Kelly Dalhousie University Dr. Sudeep Shivakumar
Ilia Makedonov University of Toronto Dr. Jean-Philippe Galanaud

 

CanVECTOR 2020-2021 Studentship Awards

Trainee Institution Supervisor
Ying (Crystal) Dai McMaster University Dr. Peter Gross
Neha Sharma McMaster University Dr. Patricia Liaw
Camille Simard McGill University Dr. Vicky Tagalakis
Joel Abraham McMaster University Dr. Paul Kim
James Chessum McMaster University Dr. Paul Kim

 

 

Bourse de début de recherche CanVECTOR 2020-2021

Trainee Institution Supervisor
Lauren Andrew University of Calgary Dr. Leslie Skeith
Lindsey Gerstein McGill University Dr. Maral Koolian
Keerat Grewal University of Toronto Dr. Kerstin de Wit
Erin Nelson University of Calgary Dr. Deepa Suryanarayan
Steven Roy University of Calgary Dr. Leslie Skeith
Cindy Shen University of Toronto Dr. Houman Khosravani
Camille Simard McGill University Dr. Maral Koolian
Daniel You University of Toronto Dr. Prism Schneider

CanVECTOR- soutient les enquêteurs cliniques en début de carrière

Dr. Kerstin de Wit 

 

Investigator
Kerstin de Wit
 
Institution
McMaster University
 
Research Program / Project
ESCAPE Program
 
Funding
2017 PSI Graham Farquharson Knowledge Translation Fellowship
2017 CAEP-CanVECTOR Grant
2017 CanVECTOR Research Start-up funding awarded to Ali Mulla: trainee under the supervision of Dr. De Wit
 
 

 

Dr. Lana Castellucci

 
Investigator
Lana Castellucci
 
Institution
University of Ottawa
 
Research Program / Project 
COBRRA Pilot Trial
COBRRA Trial 
 
Funding
CanVECTOR Pilot
CIHR (Canadian Institutes of Health Research)
 
Details / Summary
https://www.canvector.ca/research/science-platforms/clinical-trials-and-shared-platforms

Dr. Leslie Skeith

 
Investigator
Leslie Skeith
 
Institution
University of Calgary
 
Research Program / Project
APPLE Pilot Trial 
Pilot PARTUM Trial - Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
 
Funding
CanVECTOR Pilot
Canadian Institutes of Health Research (CIHR) - Spring 2019 
INVENT Dragons' Den Competition Winner - 2019 
 
Details / Summary
https://www.canvector.ca/research/science-platforms/clinical-trials-and-shared-platforms
 
Website
www.theappletrial.ca
https://www.invent-vte.com/studies/study/~787-pilot-paps

 

Dr. Deborah Siegal

 
Investigator
Deborah Siegal
 
Institution
McMaster University
 
Research Program 
Post-Bleed Management of Antithrombotic Therapy (PANTHER)
                                                                          
Projects:
Clinical Outcomes and Physician Attitudes after Factor Xa Inhibitor Related Major Bleeding: A Substudy of ANNEXA-4
 
Resumption of Anticoagulant Therapy after Anticoagulant-Related Gastrointestinal Bleeding: Systematic Review and Meta-Analysis
 
Post-Bleed Management of Antithrombotic Therapy Values and Preferences (PANTHER-VP): A Qualitative Study of Healthcare Providers
 
Post-Bleed Management of Antithrombotic Therapy (PANTHER): A Population Based Cohort Study
 
Pilot Randomized Trial of Early vs. Delayed Re-Initiation of Anticoagulant Therapy After Gastrointestinal Bleeding
 
Funding
The Heart and Stroke Foundation Emerging Research Leaders Initiative (ERLI)  
 
Details / Summary
https://www.canvector.ca/research/foundational-platforms-research/training-mentoring-and-early-career-development/panther-research-program-overview-may-18-18.pdf

 

Dr. Lisa Duffett

 
Investigator
Lisa Duffett
 
Institution
University of Ottawa
 
Research Program / Project
HIT Pilot Study
 
Funding
CanVECTOR Pilot
 
Details / Summary
https://www.canvector.ca/research/science-platforms/clinical-trials-and-shared-platforms

Dr. Paul Kim

 
Investigator
Paul Kim
 
Institution
McMaster University
 
Research Program / Project
Elucidating the role of thrombin-activable fibrinolysis inhibitor (TAFI) in venous
thromboembolism
 
Funding
CanVECTOR Early Research Leader Initiative (ERLI) Award
 
Details / Summary
Coming soon

Les activités de la plateforme des formation

1. VTE Research Training Curriculum

Un programme de formation sur la recherche sera créé, en collaboration avec les membres du Réseau, notamment les stagiaires et les jeunes investigateurs. Ce nouveau programme sera mis en œuvre aux centres de formation sur la thrombose actuels à l’échelle nationale, et il sera accessible à d’autres centres qui prévoient s’établir comme nouveaux centres de formation.

La Dre Leslie Skeith, boursière du Réseau CanVECTOR, est responsable de la première étape de cette initiative. Elle effectuera une évaluation des besoins afin de cerner les lacunes et les priorités devant être prises en compte dans le programme de formation sur la recherche liée à la TEV.

2. Élaboration d’un programme de mentorat universitaire propre au Réseau

Le mentorat est utile à chaque étape de la formation et d’une carrière et il s’est avéré un atout pour augmenter la productivité, pour favoriser le maintien en poste et la promotion en milieu universitaire des cliniciens-investigateurs/scientifiques. Le mentorat est essentiel pour obtenir du soutien à la recherche dans une discipline où le financement de bourses est très concurrentiel et pour permettre aux stagiaires de comprendre les responsabilités des investigateurs dans un contexte réglementaire de plus en plus complexe.

Le programme de mentorat se veut un programme multicentrique et multidisciplinaire visant à faire en sorte que le mentorat soit offert aux stagiaires ainsi qu’aux investigateurs en début de carrière ou non, conformément aux pratiques exemplaires. Pour amorcer l’élaboration du programme de mentorat universitaire du Réseau CanVECTOR, un atelier plénier a eu lieu le 9 juin 2016, sous la direction de la Dre Mamta Gautam, par l’entremise de l’Institut de leadership des médecins de l’Association médicale canadienne.

3. Prestation de soutien pour la recherche des professeurs en début de carrière

Parmi les facteurs qui font obstacle au succès en début de carrière, mentionnons le manque de bourses d’appui salarial, la protection du temps et de l’espace/l’équipement, et, ce qui est encore plus important, un manque de fonds de démarrage pour la recherche. Nous avons conclu un partenariat avec la Fondation des maladies du cœur et de l’AVC pour pouvoir offrir des fonds de fonctionnement aux fins de la recherche aux nouveaux investigateurs par l’entremise de l’Initiative des futurs chefs de file de la recherche (IFCFR). Ce programme vise avant tout à appuyer les nouveaux investigateurs en début de carrière. Il a pour but de permettre aux nouveaux investigateurs d’établir un programme de recherche indépendant et de faire preuve d’une productivité en recherche qui leur permettra d’obtenir des fonds auprès d’importants organismes de financement de la recherche.

Cette initiative de financement a été lancée en juin 2016: Initiative des futurs chefs de file de la recherche 2016